SECOND SIGHT MED PRODS INC - COM NEW (EYES)

CUSIP: 81362J209

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / COM NEW
Total 13F shares
275,025
Share change
-26,558
Total reported value
$269,000
Price per share
$0.98
Number of holders
12
Value change
-$27,187
Number of buys
4
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 81362J209?
CUSIP 81362J209 identifies EYES - SECOND SIGHT MED PRODS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SECOND SIGHT MED PRODS INC - COM NEW (EYES) as of Q2 2020

As of 30 Jun 2020, SECOND SIGHT MED PRODS INC - COM NEW (EYES) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 275,025 shares. The largest 10 holders included VANGUARD GROUP INC, Virtu Financial LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, WealthTrust Axiom LLC, MORGAN STANLEY, Tower Research Capital LLC (TRC), UBS Group AG, and Stonebridge Financial Planning Group, LLC. This page lists 12 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.